Literature DB >> 10772979

Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.

M C Villacres1, J Zuo, C C Bergmann.   

Abstract

CD8(+) T-cell memory is critical for protection against pathogens poorly controlled by humoral immunity. To characterize two distinct vaccine vectors, the acute and memory CD8(+) T-cell responses to an HIV-1 epitope (p18) expressed by recombinant vaccinia (vp18) and Sindbis (SINp18) viruses were compared. Whereas 9 to 13% of CD8(+) splenocytes were p18 specific during the acute response to vp18, 4% were induced by SINp18 as revealed by class I tetramer staining. Increased T-cell activation by vp18 was confirmed by higher numbers of both p18-specific IFN-gamma-secreting splenocytes and activated CD8(+) and CD4(+) T cells. Although higher frequencies of p18-specific CD8(+) T cells during primary responses correlated with higher frequencies during memory, the overall decline was only two- to threefold during the transition to memory, demonstrating equally efficient maintenance of memory in SINp18- as in vp18-immune mice. Despite modest in vivo activation, SINp18-induced CD4(+) T cells secreted substantial amounts of IFN-gamma and IL-2, potentially contributing to sustained CD8(+) memory. Collectively the data indicate that Sindbis virus recombinants provide effective vaccines for inducing protective memory CD8(+) T cells in the absence of the extensive inflammation and replication associated with vaccinia virus. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772979     DOI: 10.1006/viro.2000.0255

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.

Authors:  Ghislaine Gallez-Hawkins; Maria C Villacres; Xiuli Li; Margaret C Sanborn; Norma A Lomeli; John A Zaia
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis.

Authors:  Audrey M Chen; Nivedita Khanna; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.

Authors:  Shinya Abe; Kenji Okuda; Takehiro Ura; Asami Kondo; Atsushi Yoshida; Shinji Yoshizaki; Hiroyuki Mizuguchi; Dennis Klinman; Masaru Shimada
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

4.  Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.

Authors:  Tracey J Harvey; Itaru Anraku; Richard Linedale; David Harrich; Jason Mackenzie; Andreas Suhrbier; Alexander A Khromykh
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.

Authors:  Shinji Yoshizaki; Mayuko Nishi; Asami Kondo; Yoshitsugu Kojima; Naoki Yamamoto; Akihide Ryo
Journal:  Front Microbiol       Date:  2011-02-22       Impact factor: 5.640

6.  Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

Authors:  Gloria Gonzalez-Aseguinolaza; Luc Van Kaer; Cornelia C Bergmann; James M Wilson; John Schmieg; Mitchell Kronenberg; Toshinori Nakayama; Masaru Taniguchi; Yasuhiko Koezuka; Moriya Tsuji
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

7.  IL-15-independent antiviral function of primary and memory CD8+ T cells.

Authors:  Jun Zuo; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.